Effect of platelets Rich Plasma in recurrent cystitis in women

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017092336363N1

Enrollment

Registered

2017-11-11

Start date

2016-09-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent cystitis. cystitis

Interventions

Intervention 1: platelet rich plasma 20cc intra bladder instillation second time 2 weeks after first time and third and fourth times 1 month after previous time. Intervention 2: normal salin 20cc intr

Treatment - Drugs

Placebo

platelet rich plasma 20cc intra bladder instillation second time 2 weeks after first time and third and fourth times 1 month after previous time

normal salin 20cc intra bladder instillation second time 2 weeks after first time and third and fourth times 1 month after previous time

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: inclusionn criteria: women aged more than 18 years ; who refere to urology clinic due to recurrent cystitis exclusion criteria: any congenital urologic anomalies ; vesicoureteral reflux ; ureteral duplicasion ; ureterocele ; ureteral diverticulom ; history of other urologic diseases ; interstitial cystitis ; urinary stone ; carcinum insitue of bladder ; history of nurologic disease ; IUD or spermcidal agent usage

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Urinary infection. Timepoint: during the intervention and 2 month and 12 month after intervention. Method of measurement: urinary culture.;Irritative urinary symptoms. Timepoint: during and 2 months and 12 months after intervention. Method of measurement: ICIQ-OAB questionnare.	—

Secondary

Measure	Time frame
Age. Timepoint: during of intervention. Method of measurement: questionnare.;Weight. Timepoint: during of intervention. Method of measurement: questionnare.;Marriage. Timepoint: during of intervention. Method of measurement: questionnare.;Education. Timepoint: during of intervention. Method of measurement: questionnare.;Number of delivery. Timepoint: during of intervention. Method of measurement: questionnare.;Smoking. Timepoint: during of intervention. Method of measurement: questionnare.	—

Measure

Time frame

Age. Timepoint: during of intervention. Method of measurement: questionnare.;Weight. Timepoint: during of intervention. Method of measurement: questionnare.;Marriage. Timepoint: during of intervention. Method of measurement: questionnare.;Education. Timepoint: during of intervention. Method of measurement: questionnare.;Number of delivery. Timepoint: during of intervention. Method of measurement: questionnare.;Smoking. Timepoint: during of intervention. Method of measurement: questionnare.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmahbube mirzaei

kerman medicine universiry

mirzaeimahboubeh@yahoo.com+98 34 3222 1600

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026